GPER1 and melanoma: The activity of LNS8801 and LNS8812 were evaluated in vitro using multiple models that had previously been demonstrated to be susceptible to GPER-mediated suppression, including YUMM1.7 murine melanoma and 2838c3 murine PDAC (3, 4).